Cite
HARVARD Citation
Hercogová, J. et al. (2020). AURIEL‐PsO: a randomized, double‐blind phase III equivalence trial to demonstrate the clinical similarity of the proposed biosimilar MSB11022 to reference adalimumab in patients with moderate‐to‐severe chronic plaque‐type psoriasis. British journal of dermatology. pp. 316-326. [Online].